Explore our top-tier catalog of pharmaceutical intermediates, therapeutic peptide sequences, and specialty reagents manufactured to stringent cGMP standards for worldwide export.
Flexible and scalable manufacturing solutions across 250,000m² facilities supporting specialty catalysts, auxiliaries, and advanced organic synthesis.
Extensive portfolio of peptide APIs and intermediates certified under cGMP, supported by DMF, CEP, and full analytical validation packages.
Process optimization, route selection, green chemistry catalysis, and scalable peptide chain elongation protocols tailored for commercialization.
One-stop procurement service eliminating multi-vendor complexities through integrated chemical supply chain management and qualified sourcing.
In modern bio-organic synthesis, the selection of chemical catalysts and reaction auxiliaries determines chemical yield, optical purity (stereospecific retention), reaction velocity, and impurity profiles in complex APIs.
In Solid-Phase Peptide Synthesis (SPPS) and Liquid-Phase Peptide Synthesis (LPPS), standard peptide bond formation requires advanced coupling agents (such as HATU, HBTU, PyBOP, and DIC) operating alongside additive auxiliaries like HOBt, HOAt, or Oxyma Pure. These auxiliary additives suppress epimerization (racemization) at the C-alpha chirality center during activation of Fmoc- or Boc-protected amino acids, driving coupling efficiencies above 99.8% even in sterically hindered sequences.
Complex therapeutic peptides (such as Oxytocin, Octreotide, and custom disulfide-bridged motifs) rely on highly selective oxidants and orthogonal protecting group strategy (e.g., Acm, Trt, Mob). Auxiliary oxidants like iodine, DMSO/acidic cocktails, or thallium(III) trifluoroacetate enable precise region-specific intramolecular disulfide folding without generating high-molecular-weight aggregates or scrambled misfolded isomers.
Specialty polar aprotic solvents such as N,N-Dimethylacetamide (DMAC, CAS 127-19-5) serve as vital auxiliary media for peptide dissolution, resin swelling, and polymer membrane processing. Low moisture content (<100 ppm) and absence of free amine impurities in industrial DMAC prevent premature deprotection or side reactions during sensitive coupling steps.
Bioconjugation reagents such as AEEA (8-amino-3,6-dioxaoctanoic acid) act as hydrophilic spacer auxiliaries. Incorporating mono- or di-AEEA linkers enhances pharmacokinetic half-life, improves solubility in aqueous physiological buffers, and minimizes immunogenicity in therapeutic formulations like Inclisiran sodium or Semaglutide derivatives.
| Chemical Category | Representative Compound / CAS | Primary Auxiliary Function | Purity Standard | Commercial Application |
|---|---|---|---|---|
| Specialty Solvent | N,N-Dimethylacetamide (DMAC) [127-19-5] | Reaction Medium & Peptide Resin Solvation | ≥ 99.9% (GC) | Polymer membranes, SPPS, Synthetic Fibers |
| Hydrophilic Linker | AEEA-AEEA Auxiliary Linker | PK/PD Modification & Spacer Extension | ≥ 98.0% (HPLC) | GLP-1 Analogues, Oligonucleotide Conjugates |
| Gonadotropin Antagonist API | Cetrorelix Acetate [120287-85-6] | GnRH Receptor Antagonism | ≥ 99.0% (HPLC) | Reproductive Health, Premature Ovulation Prevention |
| Metabolic / Longevity API | NAD+ / Nicotinamide Adenine Dinucleotide | Coenzyme Redox & Cellular Energy Activation | ≥ 99.0% (HPLC) | Nutraceuticals, Anti-Aging Therapeutics |
| Metabolic Active Ingredient | Orlistat [96829-58-2] | Gastric & Pancreatic Lipase Inhibition | ≥ 98.5% (USP/EP) | Weight Management, Anti-Obesity Formulations |
Gentolex integrates technical synthesis expertise with scalable production lines to solve critical manufacturing bottlenecks across four primary industry verticals.
We provide commercial-scale supply of high-purity APIs including Semaglutide, Cetrorelix Acetate, Inclisiran sodium, and Glucagon. Backed by comprehensive analytical validation (LC-MS, NMR, Chiral HPLC, Residual Solvents), our APIs support clinical trial development through full commercial production phase.
From catalog peptides like BPC-157, CJC-1295, MOTS-C, and Sermorelin to custom sequence design with specific protected amino acids. We specialize in disulfide bridge formation, N-terminal acetylation, C-terminal amidation, and non-natural amino acid incorporation.
Providing high-volume solvent auxiliaries like industrial DMAC (CAS 127-19-5) for high-performance fiber production, pharmaceutical synthesis reaction media, lithium battery separator processing, and electronic chemical applications with strict trace-metal controls.
Gentolex operates at the intersection of modern chemical engineering and automated Industry 4.0 digital infrastructure, offering unmatched stability in global chemical procurement.
Our facility features automated DCS (Distributed Control Systems) and SCADA real-time monitoring across reactor suites ranging from 50L to 10,000L. Automated solvent recovery systems, inline Process Analytical Technology (PAT), and automated liquid-phase peptide synthesizers eliminate human operational error and deliver multi-ton consistency.
Every batch of catalyst, auxiliary reagent, or active peptide undergoes rigorous LIMS (Laboratory Information Management System) tracking. From raw material intake inspection through final micro-filtration and lyophylization, our operations adhere to 21 CFR Part 11 electronic record regulations.
With dual-site inventory buffering and strategic regional warehouse infrastructure, Gentolex mitigates geopolitical and maritime disruption risks for corporate pharmaceutical buyers worldwide.
Navigating complex international regulatory requirements demands local expertise and comprehensive documentation. Gentolex bridges local compliance gaps for seamless market entry.
We provide US FDA DMF (Drug Master Files), EU CEP/EDMF filings, and local regulatory dossiers. Complete documentation packages including Stability Data (ICH Q1A-Q1E), Impurity Profiles (ICH Q3A/Q3B), and Residual Solvent Reports (ICH Q3C) accompany commercial API shipments.
With dedicated corporate representatives in Mexico and South Africa, Gentolex provides localized customer support, real-time technical consultation, customs clearance management, and local currency/credit trading terms tailored to Latin American and African biopharmaceutical markets.
Beyond raw APIs and chemical catalysts, Gentolex offers Finished Dosage Form (FDF) licensing services, technology transfer, and laboratory setup consultation for pharmaceutical manufacturers establishing local fill-finish or peptide formulation plants.
Stay informed with technical whitepapers, chemical synthesis analyses, and therapeutic research published by Gentolex's R&D department.
Introduction to Selank Acetate API: Selank Acetate is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Derived from endogenous tuftsin, Selank is synthesized using optimized liquid-phase and solid-phase techniques to ensure high purity and low endotoxin levels suitable for biological evaluations.
View Details
Trusted Thymosin Beta-4 API Manufacturer and Global Peptide Supplier: As a specialized Thymosin Beta-4 API manufacturer, we provide high-purity Tβ4 peptide raw materials for research organizations and biopharma clients. Synthesized via controlled fragment condensation with strict stereochemical verification.
View Details
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, and inflammatory regulation. Manufactured via scalable cGMP SPPS methodology.
View Details
With the continuous development of neuroscience and peptide technology, neuroactive peptides have become a major focus. Semax, derived from an ACTH fragment, is synthesized with high purity to support target research in cellular stability and neuroprotective mechanisms.
View Details
SS-31 API (Elamipretide, MTP-131, Bendavia) is a synthetic mitochondria-targeting tetrapeptide engineered to bind cardiolipin in the inner mitochondrial membrane. By stabilizing mitochondrial energetics and reducing reactive oxygen species (ROS), SS-31 represents a landmark development in bioenergetic peptide synthesis.
View DetailsDiscover additional key active ingredients, metabolic modulators, and industrial chemical auxiliaries available for volume ordering and global contract synthesis.
Get immediate answers regarding bulk chemical procurement, custom peptide synthesis specs, analytical verification standards, and international export logistics.
